Cargando…

Therapy of pyogenic liver abscess with a primarily unknown cause

PURPOSE: Pyogenic liver abscess (PLA) is a collection of pus in the liver, often without a known direct cause. There is discord on the best diagnostic and therapeutic strategy. We aimed to examine these questions in our patient cohort. METHODS: A total of 66 out of 309 patients with PLA at our terti...

Descripción completa

Detalles Bibliográficos
Autores principales: Meister, Phil, Irmer, Hannes, Paul, Andreas, Hoyer, Dieter P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467942/
https://www.ncbi.nlm.nih.gov/pubmed/35635587
http://dx.doi.org/10.1007/s00423-022-02535-3
_version_ 1784788303652847616
author Meister, Phil
Irmer, Hannes
Paul, Andreas
Hoyer, Dieter P.
author_facet Meister, Phil
Irmer, Hannes
Paul, Andreas
Hoyer, Dieter P.
author_sort Meister, Phil
collection PubMed
description PURPOSE: Pyogenic liver abscess (PLA) is a collection of pus in the liver, often without a known direct cause. There is discord on the best diagnostic and therapeutic strategy. We aimed to examine these questions in our patient cohort. METHODS: A total of 66 out of 309 patients with PLA at our tertiary referral center between 2012 and 2020 had a primarily unknown cause. We analyzed PLA configuration, comorbidities, and whether an underlying cause could be found later. Therapy was sorted by antibiotics alone, percutaneous drainage, and primary surgery. Success was assessed by a change of initial therapy, in-hospital mortality, and mean hospital stay. RESULTS: Overall mortality was 18%; in 55%, a causative condition could be found. CRP, GGT, size, and multiple localization go along with higher mortality. Antibiotics alone had a failure rate of 82%. Percutaneous drainage was successful in 70% of cases. Surgery was mainly reserved for failed previous non-surgical treatment and had in-hospital mortality of 12%. CONCLUSIONS: PLA goes along with high mortality. In the majority of all patients, a causative condition can be identified by detailed diagnostics. Percutaneous drainage together with antibiotics is the therapy of choice and is successful in 70% of cases. If drainage is insufficient or impossible, surgery is an effective alternative.
format Online
Article
Text
id pubmed-9467942
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-94679422022-09-14 Therapy of pyogenic liver abscess with a primarily unknown cause Meister, Phil Irmer, Hannes Paul, Andreas Hoyer, Dieter P. Langenbecks Arch Surg Original Article PURPOSE: Pyogenic liver abscess (PLA) is a collection of pus in the liver, often without a known direct cause. There is discord on the best diagnostic and therapeutic strategy. We aimed to examine these questions in our patient cohort. METHODS: A total of 66 out of 309 patients with PLA at our tertiary referral center between 2012 and 2020 had a primarily unknown cause. We analyzed PLA configuration, comorbidities, and whether an underlying cause could be found later. Therapy was sorted by antibiotics alone, percutaneous drainage, and primary surgery. Success was assessed by a change of initial therapy, in-hospital mortality, and mean hospital stay. RESULTS: Overall mortality was 18%; in 55%, a causative condition could be found. CRP, GGT, size, and multiple localization go along with higher mortality. Antibiotics alone had a failure rate of 82%. Percutaneous drainage was successful in 70% of cases. Surgery was mainly reserved for failed previous non-surgical treatment and had in-hospital mortality of 12%. CONCLUSIONS: PLA goes along with high mortality. In the majority of all patients, a causative condition can be identified by detailed diagnostics. Percutaneous drainage together with antibiotics is the therapy of choice and is successful in 70% of cases. If drainage is insufficient or impossible, surgery is an effective alternative. Springer Berlin Heidelberg 2022-05-30 2022 /pmc/articles/PMC9467942/ /pubmed/35635587 http://dx.doi.org/10.1007/s00423-022-02535-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Meister, Phil
Irmer, Hannes
Paul, Andreas
Hoyer, Dieter P.
Therapy of pyogenic liver abscess with a primarily unknown cause
title Therapy of pyogenic liver abscess with a primarily unknown cause
title_full Therapy of pyogenic liver abscess with a primarily unknown cause
title_fullStr Therapy of pyogenic liver abscess with a primarily unknown cause
title_full_unstemmed Therapy of pyogenic liver abscess with a primarily unknown cause
title_short Therapy of pyogenic liver abscess with a primarily unknown cause
title_sort therapy of pyogenic liver abscess with a primarily unknown cause
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467942/
https://www.ncbi.nlm.nih.gov/pubmed/35635587
http://dx.doi.org/10.1007/s00423-022-02535-3
work_keys_str_mv AT meisterphil therapyofpyogenicliverabscesswithaprimarilyunknowncause
AT irmerhannes therapyofpyogenicliverabscesswithaprimarilyunknowncause
AT paulandreas therapyofpyogenicliverabscesswithaprimarilyunknowncause
AT hoyerdieterp therapyofpyogenicliverabscesswithaprimarilyunknowncause